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Abstract 
Background: Identification of microorganisms in positive blood cultures still relies on standard techniques such as 
Gram staining followed by culturing with definite microorganism identification. Alternatively, matrix‑assisted laser 
desorption/ionization time‑of‑flight mass spectrometry or the analysis of headspace volatile compound (VC) compo‑
sition produced by cultures can help to differentiate between microorganisms under experimental conditions. This 
study assessed the efficacy of volatile compound based microorganism differentiation into Gram‑negatives and ‑posi‑
tives in unselected positive blood culture samples from patients.
Methods: Headspace gas samples of positive blood culture samples were transferred to sterilized, sealed, and evacu‑
ated 20 ml glass vials and stored at −30 °C until batch analysis. Headspace gas VC content analysis was carried out 
via an auto sampler connected to an ion–molecule reaction mass spectrometer (IMR‑MS). Measurements covered a 
mass range from 16 to 135 u including CO2, H2, N2, and O2. Prediction rules for microorganism identification based on 
VC composition were derived using a training data set and evaluated using a validation data set within a random split 
validation procedure.
Results: One‑hundred‑fifty‑two aerobic samples growing 27 Gram‑negatives, 106 Gram‑positives, and 19 fungi and 
130 anaerobic samples growing 37 Gram‑negatives, 91 Gram‑positives, and two fungi were analysed. In anaerobic 
samples, ten discriminators were identified by the random forest method allowing for bacteria differentiation into 
Gram‑negative and ‑positive (error rate: 16.7 % in validation data set). For aerobic samples the error rate was not bet‑
ter than random.
Conclusions: In anaerobic blood culture samples of patients IMR‑MS based headspace VC composition analysis 
facilitates bacteria differentiation into Gram‑negative and ‑positive.
Keywords: Mass spectrometry, Chemical ionization, Volatile compound, Blood culture, Prediction rule, Gram 
identification
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Background
The occurrence of infectious complications in critically ill 
patients significantly impacts patient outcome by increas-
ing the mortality rate from 11 % in non-infected patients 
to 25  % in patients with infection [1]. This already high 
mortality rate is further increased up to 55.2  % when 
infectious complications progress to the development 
of sepsis or severe sepsis [2–4], a condition found with a 
prevalence of 76–300 cases per 100,000 population per 
year in the United States, France, and Germany [2, 5, 6]. 
In septic patients, about 50  % of microbial proven infec-
tions are bloodstream infections with Gram-positive bac-
teria [2]. Although empiric antibiotic therapy is usually 
initiated prior to species identification in septic patients, 
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inappropriate antibiotic therapy is present in up to 20  % 
of patients suffering from Gram-positive bacteraemia [4]. 
Thus, fast identification of the causative organism is of 
highest priority as this allows for early adoption of anti-
biotic treatment. The first step in this process, namely the 
detection of microorganism growth in blood culture broth 
bottles, has achieved high reliability and works on a semi-
automatic basis. However, subsequent procedures neces-
sary for microorganism identification as Gram-staining, 
species identification by matrix-assisted laser desorption/
ionization time of flight mass spectrometry (MALDI-TOF 
MS) or biochemical methods and antibiotic susceptibility 
testing require staff presence [7]. This limits microorgan-
ism identification and result communication to the clini-
cian to standard working hours. Thus, there is an ongoing 
urgent search for rapid and reliable diagnostic methods 
allowing for the identification of the causative microorgan-
isms. An ideal method for this purpose should be able to 
facilitate microorganism growth detection as well as Gram 
and species identification in a fully automated manner.
The analysis of blood culture broth volatile fatty acid 
composition by gas–liquid chromatography for the 
detection of anaerobic bacteraemia has gained momen-
tum back in the early 1980s [8–10]. In contrast to the 
analysis of volatile fatty acids by liquid chromatogra-
phy, where the solvent peak usually covers high volatil-
ity compounds, direct headspace gas chromatography 
(GC) allows for a more detailed investigation [11]. More 
recently, Julák et  al. applied liquid chromatography and 
headspace solid phase micro extraction GC mass spec-
trometry for the detection of volatile fatty acids originat-
ing from anaerobes in clinical samples of blood cultures 
and bronchoalveolar lavage fluid [12, 13]. However, the 
need for sample preparation prior to analysis still repre-
sents a drawback of this method. The advent of sophis-
ticated methods such as chemical noses, direct mass 
spectrometry systems like ion–molecule reaction mass 
spectrometry (IMR-MS) or selected ion flow tube MS 
(SIFT-MS) nowadays allow for direct analyses of gase-
ous samples [14–18]. Applying these systems to in vitro 
analysis of bacterial samples headspace volatile com-
pound composition makes microorganism differentiation 
possible even down to the species level [14–16, 19–21]. 
Although these results are extremely promising it must 
be noted that they were obtained under tightly controlled 
conditions with regard to broth medium, incubation 
time and number of inoculated microorganisms. Con-
sequently, the next step is to analyse clinical specimens 
to test for the presence of microorganisms. The present 
study aims to apply IMR-MS analysis of headspace gas 
VC composition to microorganism differentiation by 
using blood culture broth samples originating from an 
unselected patient population. In contrast to our previous 
work on VC based microorganism identification, where 
a defined group of microorganisms under tight experi-
mental control was analysed, the present work focused 
on true patient samples that did not undergo any sample 
preparation or selection prior to VC measurement [19, 
20]. To the best of our knowledge the present work rep-
resents the first application of VC microorganism identi-
fication on clinical samples without sample preparation.
Results
During the observation period headspace gas was col-
lected from 152 aerobic and 130 anaerobic blood culture 
broth bottles, which had been identified as positive for 
microbial growth. Aerobic samples contained 27 Gram-
negatives, 106 Gram-positives and 19 fungi whereas 
in anaerobic samples 37 Gram-negatives, 91 Gram-
positives and two fungi were identified. Due to the low 
number of fungi present in anaerobic samples, they were 
excluded from further analyses (so that 128 anaero-
bic samples were left). Among aerobic and anaerobic 
samples, the most frequently isolated pathogens within 
the family of Gram-positives were Staphylococcus epi-
dermidis (n  =  87), Enterococcus faecium (n  =  23), and 
Staphylococcus aureus (n = 17). Most frequently isolated 
Gram-negatives were Escherichia coli (n = 30) and Kleb-
siella pneumoniae (n  =  8). More detailed information 
about the frequency of isolates in anaerobic samples and 
their assignment to training and validation set is given in 
Table 1.
The headspace VC composition of each microorganism 
was tested using the measurement results obtained by 
electron-impact, xenon, and mercury ionization within 
the above described m/z range from 16 to 135. Overall, 
for each blood culture bottle a complete set of the 198 
measurements was available for analysis to discrimi-
nate between Gram-negative and -positive. In anaerobic 
conditions the prediction rules obtained by using the 
random forest method [22] resulted in CV error rates 
ranging from 9.1 to 16.4 % for Gram discrimination in the 
training set (for a range of random forest prediction rules 
obtained with previous variable selection/without previ-
ous variable selection/with previous dimension reduc-
tion by partial least squares). Note that a microorganism 
was classified as Gram-positive if more than 50 % of the 
trees of the random forest classified the microorganism 
as Gram-positive. The random forest prediction rule 
yielding the lowest error rate with 9.1 % was constructed 
based on 10 m/z signals with the highest rankings by ran-
dom forest’s Gini variable importance measure and with 
parameter values mtry = 3 and nodesize = 7, where mtry 
and nodesize denote important technical parameters of 
the algorithm in the R package randomForest (see Addi-
tional file 1 for the performance of the other prediction 
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rules). The subset of m/z’s identified in such manner 
together with the method of ionization and some tenta-
tively assigned compounds are given in Table 2. In Fig. 1, 
the corresponding signal intensities for the identified 
m/z’s are given. 
In the training set estimates for sensitivity (proportion 
of Gram-positives truly classified as Gram-positive) and 
specificity (proportion of Gram-negatives truly classified 
as Gram-negative) were 97.5 and 74.8 %, respectively and 
a value of 0.93 was obtained for the area under the curve 
(Table  3). When applying the obtained random forest 
prediction rule to the validation data set an error rate of 
16.7 % with regard to Gram identification was observed. 
The individually identified microorganisms of samples 
assigned to the validation data set as well as the results 
of Gram identification are given in Table 1. The sensitiv-
ity of the prediction rule to assign Gram-positive micro-
organisms correctly was found to be 93.3 % whereas the 
specificity, which is the correct assignment of Gram-neg-
ative microorganisms as Gram-negative, was found to be 
58.3 % within the validation data set. The observed area 
under the curve value of 0.89 was close to the ideal value 
of 1.00 for both the training and validation data set.
The analysis of species related differences in signal 
intensity under anaerobic conditions included solely 
Gram-positive bacteria as only these appeared in suffi-
cient numbers within our sample. Subsequent analyses 
aimed to compare the following bacterial species/groups: 
(i) staphylococci against streptococci, (ii) staphylococci 
Table 1 Anaerobic blood culture broth isolates, set assignment, and results of Gram identification
Gram stain Microorganism Isolates (n = 128) Gram discrimination (n = 42)
Training set (n = 86) Validation set (n = 42) Identified (n = 35) Misidentified (n = 7)
Positive Enterococcus faecium 7 3 2 1
Listeria monocytogenes 1 – – –
Propioninbacterium acnes 6 1 1 –
Streptococcal sp.
Streptococcus canis 1 – – –
S. constellatus – 1 1 –
S. gallolyticus 2 3 3 –
S. hominis 1 – – –
S. mitis – 2 2 –
S. pneumoniae 2 – – –
Staphylococcal sp.
Staphylococcus aureus 6 2 2 –
S. aureus, methicillin‑resistant 4 – – –
S. capitis 4 – – –
S. epidermidis 24 14 14 –
S. haemolyticus 1 2 1 1
S. lugdunensis 2 2 2 –
Negative Enterobacter aerogenes 2 – – –
Escherichia coli 16 7 5 2
Citrobacter freundii – 1 1 –
Klebsiella oxytoca 1 1 1 –
Klebsiella pneumoniae 3 1 – 1
Proteus mirabilis – 1 – 1
Pseudomonas aeruginosa 1 – – –
Salmonella paratyphi 1 – – –
Salmonella typhi 1 1 – 1
Table 2 Ionization method and  masses identified by  the 
random forest method
EI-MS electron impact mass spectrometry; IMR-MS ion–molecule reaction mass 
spectrometry
a Signalling at m/z 36 is 4.20 % of m/z 34 signalling which matches exactly the 
expected value of 4.21 % for the presence of the 34S isotope of H2S
Ionization Ion Identified masses [m/z] Tentative compound
EI‑MS e− 2 H2
IMR‑MS Hg+ 34–36, 64, 66 H2S (34)
a
Xe+ 35, 64, 76, 80 –
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against enterococci, (iii) staphylococci against other 
Gram-positives, and (iv) enterococci against other Gram-
positives. Although several differences appeared between 
bacterial species/groups these differences were no longer 
significant after adjusting the results for multiple com-
parisons using the Bonferroni-Holm method.
In aerobic conditions, the best prediction rule for Gram 
discrimination yielded a CV error rate of 28.4  % based 
on the training data and was obtained by using diago-
nal linear discriminant analysis. This error rate is only 
marginally smaller than the rate of 30.3 % that would be 
achieved if all observations were rated as Gram-positive 
(since Gram-negatives and fungi make up about 30.3 % of 
the observations in the training data set). Thus, the pre-
diction rule was not considered to be of any practical use 
and no further analyses were performed and no data are 
shown.
Discussion
When analysing the VC headspace composition of 
patients’ blood culture samples for microorganism detec-
tion and identification several problems arise. The main 
problem one encounters is the lack of standardization 
procedures. Blood culture samples of patients will largely 
vary in their composition for technical and patient- spe-
cific reasons. Technical reasons include different mixing 
volumes of blood added to the culture broth sample, vari-
ations in temperature exposure and time prior to incu-
bation, exposure of the blood culture bottle content to 
ambient air via the inserted needle, and insertion of the 
needle through a liquid disinfectant surface. The latter 
two of these can lead to headspace contaminations with 
ambient air or disinfectants. Possible, and even more 
important, factors to be considered for patient-specific 
reasons are variations in age, gender, actual disease, pre-
existing diseases, organ insufficiencies or failures, applied 
organ support, medication, nutrition, and inflammation. 
Thus, the results presented here must be interpreted by 
taking these factors into account. VC signals detected 
by the instrument may either originate from the broth 
medium, the body fluid examined, present microorgan-
isms, physiological- or pathophysiological conditions, use 
of medications, extracorporeal circuits, or contaminants. 
The clearest case will be if signals are identified attribut-














































p=0.004 p < 10−3 p < 10−3 p < 10−4 p < 10−3 p=0.005 p=0.035 p=0.165 p=0.003 p=0.035
Fig. 1 Identified discriminators for differentiation between Gram‑negative and Gram‑positive bacteria. Boxplot of random forest method identi‑
fied discriminators for the training (left) and validation (right) set for differentiation into Gram‑negative (white boxplots) and Gram‑positive (grey 
boxplots) bacteria in anaerobic samples. Discriminators are given at their mass to charge ratio (m/z) of appearance. H2 (m/z = 2) was identified using 
electron impact ionization. Compounds detected at m/z = 34–36, 64 and 66 were measured by chemical ionization using mercury as primary ion. 
Compounds detected at m/z = 35, 64, 76 and 80 were measured by chemical ionization using xenon as primary ion. Signal intensity is given in 
counts per second (cps). p values were computed using a Kolmogorov–Smirnov test for testing if distributions were equal in both groups. Due to 
a previous H2 calibration, negative H2 values were obtained. Therefore, for the graphical presentation a uniform projection of the H2 values into the 
positive was performed
Table 3 Accuracy of  the random forest prediction rule 
in training and validation data
AUC area under the curve
Training set (n = 86) Validation set (n = 42)
Error rate (%) 9.1 16.7
Sensitivity (%) 97.5 93.3
Specificity (%) 74.8 58.3
AUC 0.93 0.89
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for example it is the case for 2-pentylfuran produced by 
Aspergillus fumigatus [23]. Unfortunately, this applies 
only to a minority of VCs detected as numerous VCs are 
also produced by human metabolism or are present in 
nutrition or medication [24, 25]. Therefore, we consider 
the finding of discriminating bacteria into Gram-neg-
atives and -positives at an error rate of about 17  % still 
impressive given the numerous factors possibly affecting 
the sample headspace VC composition that were beyond 
our control. This can certainly be achieved more accu-
rately by performing a Gram stain, but Gram staining 
requires the presence of staff, which is usually not pre-
sent on a 24 h basis. In contrast the method of VC head-
space gas analysis can be fully automated and even allows 
direct messaging of the results via a communication net-
work to the responsible physician independent of routine 
working hours. Thus the work presented here serves as 
a “proof of principle” method that can be substituted 
in the future with a down-scaled MS covering just the 
absolute necessary number of VC’s required for Gram or 
species identification. The reasons why the method pre-
sented here did not work in aerobic blood culture sam-
ples so far remains unclear at the moment. One possible 
reason might be the ventilation of aerobic blood culture 
samples against ambient air in order to “oxygenate” the 
sample; however this assumption is only speculative. In a 
previous study performed under aerobic conditions using 
lysogeny broth as culture medium [19], we were able to 
differentiate between staphylococcal, streptococcal and 
enterococcal species. Further studies may therefore lead 
to an adapted methodology that also accomplishes Gram 
differentiation under aerobic conditions.
A steadily increasing number of publications including 
our own results report the capability of either direct mass 
spectrometric as well as GC–MS methods to differenti-
ate between different microorganisms at the species or 
even strain level [15, 16, 19–21, 26, 27]. A comprehensive 
review on the subject of mass spectrometric detection of 
microorganism and mammalian cells was recently pub-
lished by Chingin et al. [28]. Although promising, it must 
be noted that so far results were obtained under experi-
mental conditions with stringent control of broth media 
and bacterial inoculate. Using these precisely controlled 
conditions the spiking of blood samples with microor-
ganisms allowed for the identification of species spe-
cific VCs [14, 29]. Up to now, analyses in blood culture 
samples and other body fluids of patients with suggested 
infections were carried out recently by Julák et al. using 
liquid GC–MS for the identification of volatile and non-
volatile fatty acids (VFA/NVFA) that allows identifying 
anaerobic bacteria [12, 13]. More recently, Schubert et al. 
applied MALDI-TOF MS for the analysis of clinical blood 
culture samples, which allowed correct identification of 
86.5  % of microorganisms within 25  min of blood cul-
ture positive detection [7]. Furthermore, Grundt et  al. 
presented a mass spectrometry based assay for antibi-
otic susceptibility testing by detecting the β-lactamase 
hydrolysis product of ampicillin [30].
Our “proof of principle” analysis did not include nega-
tive blood culture samples as they became available for 
analysis only after completion of the routine microbiolog-
ical investigation period of seven days for blood culture 
samples. Due to concerns in comparing blood culture 
samples after such a long period of time with samples 
detected as “positive” by the BACTEC FX system within 
an on average considerable shorter time period of 2 days 
negative samples were disregarded. Nevertheless, further 
development of the method should certainly include on-
line analysis during the whole period of culturing irre-
spective of the presence of microorganisms to control for 
matrix interferences and avoid false positive detection of 
negative samples.
Conclusions
This study impressively shows that the analysis of VCs in 
the headspace of anaerobic blood culture samples origi-
nating from an unselected patient population has the 
potential to differentiate between Gram-negative and 
-positive bacteria despite a large biodiversity present 
in human blood culture samples due to factors such as 
age, gender, underlying disease and comorbidity, organ 
insufficiencies and medication. Our results are promis-
ing as they show that the method is technically feasible 
and allows for the identification of a bacteria Gram typi-
cal VC pattern for the first time. Given the ability of the 
method for automation of blood culture sample analysis 
it offers the potential to decrease the time to Gram iden-
tification, which represents important information to the 
clinician. Results of VC headspace analysis can be pro-
cessed without the need of staff presence even outside 
the usual working hours and provided to the clinician by 
communication devices to shorten the time required for 
adaptations of antibiotic treatment in response to micro-
bial test results.
Methods
The Ethics Committee of the Medical Faculty of the Lud-
wig-Maximilians-University of Munich waived the need 
for written informed consent as no patient-related data 
were collected and stored for the present work.
Blood cultures and headspace gas sampling
Headspace gas samples of blood culture broths (BD 
BACTEC Plus Aerobic/F and Anaerobic/F blood cul-
ture media; Becton–Dickinson, Heidelberg, Germany) 
from patients with suspected infection were collected 
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from September to December 2011 when identified as 
positive for microorganism growth by the BACTEC FX® 
(BD, New Jersey, USA) blood culture system. Access to 
the blood culture broth headspace gas was accomplished 
by introducing a three-way stopcock locked sterile nee-
dle through the penetrable membrane. A 25  ml sample 
of headspace gas was collected under sterile conditions 
prior to Gram staining of the blood culture broth. The 
headspace sample was transferred into sterilized evacu-
ated 20  ml glass vials (Macherey–Nagel, Dueren, Ger-
many) and stored at −30  °C until batch analysis. At the 
time of analysis samples were transferred into a head-
space auto sampler (G1888, Agilent technologies, Santa 
Clara, California, USA) and heated within the integrated 
oven to a temperature of 65.0 °C. For headspace gas anal-
ysis the vials cup was penetrated with a needle and the 
sample gas was passed through a transfer line heated to 
140 °C to the IMR- MS (VF Services GmbH, Absam, Aus-
tria) where analyses took place [20].
Phenotype identification
Gram staining of the blood culture broth sample was car-
ried out immediately following headspace gas collection. 
Subsequently, depending on Gram staining results, sub-
cultures on Bacteroides Bile Esculin, Candiselect, Choco-
late, Columbia blood, MacConkey II, Nagler, Sabouraud, 
or Vitamin K1 agars were incubated at a temperature of 
37  °C. The following day definite isolate identification 
was performed using MALDI-TOF MS (MALDI Bio-
typer, BrukerDaltonik GmbH, Bremen, Germany). A 
Phoenix® (Phoenix, BD Diagnostic Systems, Sparks, MD) 
automated microbiology system was used for antibiotic 
susceptibility testing.
The IMR‑MS system
A detailed description of the equipment (Airsense Com-
pact, VF Services GmbH, Absam, Austria) has been 
published previously [19, 20, 31–33]. In brief, the MS 
system combines two mass spectrometric techniques, 
a conventional electron-impact mass spectrometer (EI-
MS) for the detection of high e.g. Vol %-concentrations 
and an IMR-MS. The latter provides a highly sensitive 
method for on-line and off-line sampling of organic 
and inorganic compounds and has already been used to 
determine volatile compounds in exhaled breath [17, 31, 
32, 34–36]. The IMR-MS can switch between different 
positively charged primary ion beams. Available primary 
ions are generated from krypton, mercury, or xenon gas 
by electron-impact ionization. These positively charged 
atomic ions interact with neutral sample gas molecules. 
Two-body collision processes result in the formation of 
product ions whenever the ionization potential of the 
sample molecule is less than the potential energy of the 
incoming primary ion. Differences in ionization poten-
tials between primary and product ions may result in a 
bond rupture and hence a lower molecular weight frag-
ment ion. However, in contrast to significant molecule 
fragmentation observed when applying high-energy 
electron-impact ionization, the IMR-MS low-energy soft 
ionization method results in less molecule fragmenta-
tion. In our experiments, mercury and xenon ions were 
used as primary ions. The IMR-MS mass separation is 1 
u over the mass range. Between sample measurements 
the IMR-MS lines where flushed with N2 (purity 5.0) to 
avoid carry over effects.
Based on previous experience [19, 20] with measure-
ments of VCs produced by bacteria the following masses 
were selected for analysis with a dwell time of 300  ms 
per mass: using xenon for chemical ionization 16, 17, 20, 
21, 26, 27, 29, 30, 32, 33, 35, and 38–122; and mercury 
for chemical ionization: 17, 19, 28–31, 33–123, and 135. 
Simultaneous measurements of CO2, H2, H2O, N2, and 
O2 concentrations were performed using the EI-MS facil-
ity available in the Airsense Compact system.
Statistical analysis
Prediction rules were derived using the Bioconduc-
tor package CMA [37, 38] within the framework of the 
statistical software R. The Gram stain equivalent (either 
Gram-positive or Gram-negative) was considered as 
the response to be predicted by the prediction rule. The 
CMA package provides automated variable selection, 
parameter tuning, classifier construction and evaluation 
for a wide range of standard methods used for the analy-
sis of complex high dimensional data. Several predic-
tion methods, such as boosting, random forest, support 
vector machines, penalized logistic regression, k nearest 
neighbours, feed forward and probabilistic neural net-
works, discriminant analysis, elastic net and lasso-type 
methods, were applied to obtain prediction rules with 
the highest possible accuracy. Where applicable, methods 
were also applied after variable selection and/or dimen-
sion reduction of the predictor space. Details are given in 
Additional file 1.
To assess reliably the performance of the constructed 
prediction rule and avoid over-optimism a random split 
validation procedure was adopted [39, 40]. Prior to analy-
sis the data set was randomly split into two non-overlap-
ping subsets (ratio 2:1). Stratified splitting was conducted 
to preserve the distribution of fungi, Gram-negative and 
-positive in both subsets. The larger subset (denoted as 
training set) was used to train and to evaluate a large 
number of diverse candidate prediction rules and to 
select the best one. The prediction rule with the lowest 
error rate was regarded as the best one. The smaller sub-
set (denoted as validation set) was used for the validation 
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of the previously chosen prediction rule in order to 
obtain a reliable estimate of the expected performance 
of the prediction rule on future independent data. The 
assessment of the error of the candidate prediction rules 
in the training data set was based on fivefold cross valida-
tion (CV). Tuning parameters were optimized via nested 
cross validation, i.e. in each CV-fold a further internal 
CV is executed in which an optimal value for a tuning 
parameter is selected out of a range of candidate values. 
To obtain more stable estimates for the error rate 100 
repetitions of fivefold CV were conducted. The analyses 
were performed separately for aerobic and for anaerobic 
blood cultures.
Additional analyses were performed to further dif-
ferentiate between bacterial species within the group of 
Gram-positives. Prediction rules could not be derived 
due to the small sample size. Univariate subgroup analy-
ses for detecting significant differences in the distribution 
of m/z’s for bacterial species were conducted using the 
Kolmogorov–Smirnov test. This nonparametric test was 
applied for each m/z to identify significant differences in 
distributions for two subgroups. p values were adjusted 
for multiple testing using the Bonferroni-Holm method.
The random forest prediction rule as well as the data 
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